Literature DB >> 15265095

A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths.

S Pirnay1, S W Borron, C P Giudicelli, J Tourneau, F J Baud, I Ricordel.   

Abstract

AIMS: To assess the trends in the number, mortality and the nature of forensic cases involving toxicological detection of buprenorphine or methadone among toxicological investigations performed in Paris from June 1997 to June 2002.
DESIGN: Retrospective, 5 year study with review of premortem data, autopsy, police reports, hospital data, and post-mortem toxicological analyses. SETTING AND PARTICIPANTS: 34 forensic cases of buprenorphine and 35 forensic cases of methadone detection among 1600 toxicological investigations performed at the Laboratory of Toxicology in the Medical Examiner's Office in Paris. MEASUREMENTS AND
RESULTS: Therapeutic, toxic or lethal drug concentrations were defined based upon the results of blood analyses and the published literature. Drug concentrations were cross-referenced with other available ante- and post-mortem data. Subsequently, we classified a 'clear responsibility', 'possible responsibility' or 'not causative' role for buprenorphine or methadone in the death process, or 'no explanation of death'. Buprenorphine and methadone can be regarded as being directly implicated in, respectively, four of 34 death cases (12%) and three of 35 death cases (9%), and their participation in the lethal process is strongly plausible in eight (buprenorphine) and 11 (methadone) additional deaths.
CONCLUSIONS: Analysis of causes of death reveals the difficulties in determining the role of substitution drugs in the death process, as many other factors may be involved, including circumstances surrounding death, past history, differential selection of subjects into either substitution modality and concomitant intake of other drugs (especially benzodiazepines and neuroleptics). The potential for synergistic or additive actions by other isolated molecules-particularly opioids, benzodiazepines, other psychotropes and alcohol-must be also considered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265095     DOI: 10.1111/j.1360-0443.2004.00790.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  25 in total

1.  Gender differences in pharmacokinetics of maintenance dosed buprenorphine.

Authors:  David E Moody; Wenfang B Fang; Jerdravee Morrison; Elinore McCance-Katz
Journal:  Drug Alcohol Depend       Date:  2011-04-23       Impact factor: 4.492

2.  Is methadone too dangerous for opiate addiction?

Authors:  Jason Luty; Colin O'Gara; Mohammed Sessay
Journal:  BMJ       Date:  2005-12-10

Review 3.  Methadone tolerance testing in drug misusers.

Authors:  Adam Bakker; Cindy Fazey
Journal:  BMJ       Date:  2006-11-18

4.  Trends in methadone-related deaths in Zurich.

Authors:  Patrick Johannes Laberke; Christine Bartsch
Journal:  Int J Legal Med       Date:  2010-03-27       Impact factor: 2.686

5.  Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland.

Authors:  Becky L Genberg; Mirinda Gillespie; Charles R Schuster; Chris-Ellyn Johanson; Jacquie Astemborski; Gregory D Kirk; David Vlahov; Shruti H Mehta
Journal:  Addict Behav       Date:  2013-08-17       Impact factor: 3.913

6.  Buprenorphine-related deaths: unusual forensic situations.

Authors:  Anne-Laure Pelissier-Alicot; Caroline Sastre; Valerie Baillif-Couniou; Jean-Michel Gaulier; Pascal Kintz; Erika Kuhlmann; Pierre Perich; Christophe Bartoli; Marie-Dominique Piercecchi-Marti; Georges Leonetti
Journal:  Int J Legal Med       Date:  2010-04-06       Impact factor: 2.686

Review 7.  Buprenorphine in cancer pain.

Authors:  Mellar P Davis
Journal:  Support Care Cancer       Date:  2005-07-12       Impact factor: 3.603

8.  Additive Effects of Cointoxicants in Single-Opioid Induced Deaths.

Authors:  Marcella H Sorg; D Leann Long; Marie A Abate; James A Kaplan; James C Kraner; Margaret S Greenwald; Thomas A Andrew; Steven L Shapiro; Jamie A Wren
Journal:  Acad Forensic Pathol       Date:  2016-09

9.  Relationship between methadone and EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) in urine samples from Norwegian prisons.

Authors:  Jean-Paul Bernard; Mimi Stokke Opdal; Ritva Karinen; Jørg Mørland; Hassan Z Khiabani
Journal:  Eur J Clin Pharmacol       Date:  2007-06-19       Impact factor: 2.953

10.  Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans.

Authors:  M A Huestis; E J Cone; S O Pirnay; A Umbricht; K L Preston
Journal:  Drug Alcohol Depend       Date:  2012-12-14       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.